Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06932289

Integrating Metabolic and Vascular Sensors to Monitor Cardiometabolic Disorders After Nutrition Interventions

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
54 (estimated)
Sponsor
VA Greater Los Angeles Healthcare System · Federal
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

It is a 12-week study. The participants will follow three different diets, and during each diet period, and the participants will wear our device, and blood samples will be collected.

Detailed description

The investigators will conduct a randomized, controlled crossover intervention study. The investigators will enroll 54 participants, aged \>18 years, BMI \>25 kg/m2 with metabolic syndrome. During the first phase, all participants will consume their habitual diet for 2 weeks to establish baseline. Then participants will be randomized to either a Mediterranean diet (MED), high-fat/low carb diet (HF/LC), or low-fat diet (LF) for 14 days with 2 weeks washout between the different diets. The wearable system will monitor basal levels and the changes for glucose, cholesterol, TG, and NO through sweat analysis and HR, HRV, and PWV for carotid arterial stiffness during each diet intervention.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMediterranean diet (MED), high-fat/low carb diet (HF/LC), and low-fat diet (LF)Participants will be randomized to either Mediterranean diet (MED), high-fat/low carb diet (HF/LC), or low-fat diet (LF).
DEVICEThe integrated sweat sensor and vascular sensor (wearable)The integrated sweat sensor and vascular sensor will be worn of each diet period.
DEVICEcontinuous glucose monitor (CGM)A continuous glucose monitor (CGM) will be placed on the patients during each diet period.

Timeline

Start date
2025-05-01
Primary completion
2029-04-30
Completion
2029-05-01
First posted
2025-04-17
Last updated
2025-04-17

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06932289. Inclusion in this directory is not an endorsement.